Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
European Journal of Cancer2013Vol. 49(12), pp. 2698–2704
Citations Over TimeTop 10% of 2013 papers
Víola B. Weeda, Maciej Murawski, Amanda J. McCabe, Rudolf Maibach, Laurence Brugières, Derek Roebuck, Monique Fabrè, A. Zimmermann, J. B. Otte, Michael Sullivan, Giorgio Perilongo, Margaret Childs, Penelope Brock, József Zsíros, J. Plaschkes, Piotr Czauderna, Daniël C. Aronson
Related Papers
- → Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers(2008)83 cited
- → Resection versus transplantation for hepatocellular carcinoma exceeding Milan criteria within increasing donor shortage(2017)6 cited
- → Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant.(2015)3 cited
- [Living donor liver transplantation for the patient with hepatocellular carcinoma].(2004)